
Neurocognitive Assessment And Rehabilitation Market Report 2026
Global Outlook – By Components (Neurocognitive Assessment Testing, Neurorehabilitation Therapy), By Providers (Rehab Centers, Hospital And Clinics, Homecare Settings, Physiotherapy Centers), By Organization Size (Large Enterprises, Small And Medium-Sized Enterprises (SMEs)) - Market Size, Trends, And Global Forecast 2026-2035
Neurocognitive Assessment And Rehabilitation Market Overview
• Neurocognitive Assessment And Rehabilitation market size has reached to $14.65 billion in 2025 • Expected to grow to $22.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.3% • Growth Driver: Rising Prevalence Of Neurological Disorders Fuels Growth In Neurocognitive Assessment And Rehabilitation Market • Market Trend: Innovation In Digital Cognitive Screening Tools Enhances Early Detection And Assessment Accuracy In Neurocognitive Care • North America was the largest region in 2025.What Is Covered Under Neurocognitive Assessment And Rehabilitation Market?
Neurocognitive rehabilitation refers to therapeutic interventions aimed at diagnosing and treating cognitive impairments caused by neurological conditions, brain injuries, or psychological disorders. It involves a series of standardized tests and clinical evaluations designed to measure cognitive functions such as memory, attention, language, and problem-solving skills. The main components of neurocognitive assessment and rehabilitation are neurocognitive assessment testing and neurorehabilitation therapy. Neurocognitive assessment testing is the evaluation of a person's cognitive functions such as memory, attention, and problem-solving skills to understand their brain health and detect any impairments or disorders. The providers are rehab centers, hospitals and clinics, home care settings, and physiotherapy centers, with organization sizes including large enterprises, and small and medium-sized enterprises (SMEs).
What Is The Neurocognitive Assessment And Rehabilitation Market Size and Share 2026?
The neurocognitive assessment and rehabilitation market size has grown strongly in recent years. It will grow from $14.65 billion in 2025 to $16.02 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising prevalence of cognitive impairment disorders, early adoption of standardized neurocognitive tests, growth of hospital-based rehabilitation programs, increased awareness of neurological assessment, development of paper-based cognitive testing methods.What Is The Neurocognitive Assessment And Rehabilitation Market Growth Forecast?
The neurocognitive assessment and rehabilitation market size is expected to see strong growth in the next few years. It will grow to $22.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to expansion of digital cognitive testing platforms, rising adoption of vr-based rehabilitation therapy, increasing use of ai-enabled assessment software, growth in demand for homecare cognitive therapy solutions, development of advanced neuromodulation devices. Major trends in the forecast period include increasing adoption of computerized cognitive assessment tools, growing demand for virtual reality-based rehabilitation, rising use of standardized neuropsychological tests, expansion of neurofeedback and tms-based therapy, increasing preference for home-based cognitive rehabilitation.Global Neurocognitive Assessment And Rehabilitation Market Segmentation
1) By Components: Neurocognitive Assessment Testing, Neurorehabilitation Therapy 2) By Providers: Rehab Centers, Hospital And Clinics, Homecare Settings, Physiotherapy Centers 3) By Organization Size: Large Enterprises, Small And Medium-Sized Enterprises (SMEs) Subsegments: 1) By Neurocognitive Assessment Testing: Standardized Tests, Computerized Neurocognitive Assessments, Paper-Based Neurocognitive Tests 2) By Neurorehabilitation Therapy: Cognitive Behavioral Therapy (CBT), Virtual Reality Therapy, Transcranial Magnetic Stimulation (TMS), Neurofeedback Therapy, Physical Therapy And Occupational TherapyWhat Is The Driver Of The Neurocognitive Assessment And Rehabilitation Market?
The increasing prevalence of neurological disorders is expected to propel the growth of the neurocognitive assessment and rehabilitation market going forward. Neurological disorders are medical conditions that affect the nervous system, including the brain, spinal cord, and nerves, leading to symptoms such as muscle weakness, coordination problems, and cognitive impairments. Neurological disorders can be attributed to a combination of factors with an aging population and the prevalence of age-related conditions such as Alzheimer's disease and Parkinson's disease. Neurocognitive assessment provides insights into cognitive function, aiding in diagnosis and treatment planning for neurological disorders, while rehabilitation interventions aim to optimize neural functioning and enhance quality of life through targeted therapies and strategies. For instance, in October 2023, according to the World Federation of Neurology, a UK-based charity, reflecting an accelerating global health burden, neurological disorders now represent the second-leading cause of death and the primary cause of disability worldwide, with more than 40 percent of the global population affected in 2023 and the number of individuals living with brain disease projected to nearly double by 2050. Therefore, the increasing prevalence of neurological disorders drives the growth of the neurocognitive assessment and rehabilitation industry.Key Players In The Global Neurocognitive Assessment And Rehabilitation Market
Major companies operating in the neurocognitive assessment and rehabilitation market are Cogstate Ltd, Posit Science Corporation, Lumos Labs Inc., The Magstim Company Ltd, MindMaze SA, CogniFit Inc, Cambridge Cognition Holdings plc, ImPACT Applications Inc., Neurotrack Technologies Inc., Neuroelectrics Corporation, SCHUHFRIED GmbH, Constant Therapy Health Inc., NeuronUP S.L., Qbtech AB, Neurometrix Inc., CogniVue Corporation, Neurohealth Associates LLP, BrainTrain Inc., NeuroEM Therapeutics Inc., HASOMED GmbH, Neurosoft Bioelectronics Corporation, AnthroTronix Inc., Flow Neuroscience AB, NPsych LimitedGlobal Neurocognitive Assessment And Rehabilitation Market Trends and Insights
Major companies operating in the neurocognitive assessment and rehabilitation market are focusing on developing advanced solutions, such as digital cognitive screening tools, to improve early detection of cognitive impairment and support clinical decision-making. Digital cognitive screening tools refer to software-based assessments that evaluate functions such as attention, memory, processing speed, and executive function, enabling faster and more accessible evaluation in clinical settings. For instance, in March 2024, Linus Health, a US-based digital health company specializing in brain health assessment, launched two new evidence-based cognitive screening additions to its platform a Hearing Screener and the Digital Trail Making Test Part B (D-TMT Part B) unveiled at HIMSS24. These tools are designed to enhance the identification of cognitive decline by offering rapid, clinically validated assessments that augment routine screening practices and support earlier intervention.What Are Latest Mergers And Acquisitions In The Neurocognitive Assessment And Rehabilitation Market?
In September 2023, Enlyte Group LLC, a US-based software company, acquired Therapy Direct LLC from Upstream Rehabilitation for an undisclosed amount. The acquisition aims to strengthen Enlyte's clinical services and network offerings, demonstrating a commitment to providing quality casualty solutions and services to meet evolving customer needs. Therapy Direct is a US-based subsidiary of Upstream Rehabilitation Inc. and a provider of medical rehabilitation services, specifically physical therapy.Regional Outlook
North America was the largest region in the neurocognitive assessment and rehabilitation market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Neurocognitive Assessment And Rehabilitation Market?
The neurocognitive assessment and rehabilitation market consists of revenues earned by entities by providing services for individualized rehabilitation planning, cognitive training, psychoeducation, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurocognitive assessment and rehabilitation market also includes sales of software applications, wearable devices, virtual reality systems, brain stimulation devices, and specialized exercise equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Neurocognitive Assessment And Rehabilitation Market Report 2026?
The neurocognitive assessment and rehabilitation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neurocognitive assessment and rehabilitation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Neurocognitive Assessment And Rehabilitation Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $16.02 billion |
| Revenue Forecast In 2035 | $22.02 billion |
| Growth Rate | CAGR of 9.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Components, Providers, Organization Size |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Cogstate Ltd, Posit Science Corporation, Lumos Labs Inc., The Magstim Company Ltd, MindMaze SA, CogniFit Inc, Cambridge Cognition Holdings plc, ImPACT Applications Inc., Neurotrack Technologies Inc., Neuroelectrics Corporation, SCHUHFRIED GmbH, Constant Therapy Health Inc., NeuronUP S.L., Qbtech AB, Neurometrix Inc., CogniVue Corporation, Neurohealth Associates LLP, BrainTrain Inc., NeuroEM Therapeutics Inc., HASOMED GmbH, Neurosoft Bioelectronics Corporation, AnthroTronix Inc., Flow Neuroscience AB, NPsych Limited |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
